Filing Details

Accession Number:
0001213900-21-016984
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-22 16:53:21
Reporting Period:
2021-03-18
Accepted Time:
2021-03-22 16:53:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1000683 Blonder Tongue Laboratories Inc BDR Radio & Tv Broadcasting & Communications Equipment (3663) 521611421
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1219743 S Eric Skolnik C/O Blonder Tongue Laboratories, Inc.
One Jake Brown Road
Old Bridge NJ 08857
Senior Vice President - Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.001 Disposition 2021-03-18 4,998 $1.59 16,704 No 4 S Direct
Common Stock, Par Value $0.001 Disposition 2021-03-19 3,502 $1.49 13,202 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Par Value $0.001 Employee Stock Option (right to buy) Acquisiton 2021-03-19 60,000 $0.00 60,000 $1.48
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
60,000 2031-03-19 No 4 A Direct
Footnotes
  1. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.59 to $1.60. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.50 to $1.51. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote
  3. The stock option was granted under the 2016 Employee Equity Incentive Plan.
  4. The exercise price equals the fair market value (equal to the closing selling price as reported on the NYSE American) of the common stock on the grant date.
  5. The stock option vests in three equal installments of one-third each on the first, second and third anniversary of the date of grant.